1-4 of 4
Kristan M. Augustin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FLAG-IM (Fludarabine, Ara-C, G-CSF, Idarubicin, Mylotarg) Is an Effective Salvage Regimen Producing High Rates of Remission (CR+CRi) in Relapsed/Refractory AML.

Sagun D. Goyal, MD, MSc, Geoffrey L. Uy, MD, Kristan M. Augustin, PharmD, Lindsay Hladnik, PharmD, Camille N. Abboud, MD, Amanda F. Cashen, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2007) 110 (11): 1855.
https://doi.org/10.1182/blood.V110.11.1855.1855
Published: 2007
Journal Articles

Salvage Therapy with Flag/Idarubicin/Mylotarg (Flag-IM) Results in a Superior CR/CRp Rate and Low Toxicity When Compared to Mitoxantrone/Etoposide/Cytarabine (MEC) in Patients with Relapsed and Refractory AML.

Brian A. Van Tine, MD, PhD, Kristan M. Augustin, Ph.D., David I. Kuperman, M.D., Bruno Nervi, M.D., Peter Westervelt, M.D./Ph.D., John F. DiPersio, M.D./Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4576.
https://doi.org/10.1182/blood.V108.11.4576.4576
Published: 2006
Journal Articles

Prolonged Engraftment and/or Primary Graft Failure Following Allogenic Stem Cell Transplant in Patients Treated with Dasatinib.

Stephanie S. Bauer, APRN-BC, Jennifer C. Dykeman, BA, Kristan M. Augustin, PharmD, John F. DiPersio, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 5259.
https://doi.org/10.1182/blood.V108.11.5259.5259
Published: 2006
Journal Articles

Comparison of Outcomes in Elderly Patients with Non-Hodgkins Lymphoma Undergoing High-Dose Chemotherapy to Their Younger Counterparts: Greater Morbidity but No Significant Impact on Overall Survival.

Tanya M. Wildes, MD, Kristan M. Augustin, PharmD, Ravi Vij, MD, Nancy Bartlett, MD, John F. DiPersio, MD, PhD, Steven M. Devine, MD
Journal: Blood
Blood (2005) 106 (11): 2086.
https://doi.org/10.1182/blood.V106.11.2086.2086
Published: 2005